Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
about
The emerging diversity of neuromuscular junction disordersA systematic review of population based epidemiological studies in Myasthenia Gravis.Nationwide population-based epidemiological study of myasthenia gravis in taiwanTreatment of Myasthenia Gravis in Patients with Elderly Onset at Advanced AgeMyasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology.Association of HLA-DQB1∗05:02 and DRB1∗16 Alleles with Late-Onset, Nonthymomatous, AChR-Ab-Positive Myasthenia Gravis.Myasthenia gravis: a clinical-immunological update.Incidence and Prevalence of Myasthenia Gravis in Korea: A Population-Based Study Using the National Health Insurance Claims Database.Diagnostic use of autoantibodies in myasthenia gravis.Thymus pathology observed in the MGTX trial.Incidence of Autoimmune Myasthenia Gravis in a Health Maintenance Organization in Buenos Aires, Argentina.Myasthenia gravis: recent advances in immunopathology and therapy.Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases.Epidemiology of myasthenia gravis in Austria: rising prevalence in an ageing society.Myasthenia gravis requiring pyridostigmine treatment in a national population cohort.Late-onset myasthenia not on the increase: a nationwide register study in Denmark, 1996-2009.Incidence of acetylcholine receptor-antibody-positive myasthenia gravis in South Africa.Smoking and socio-economic status may affect myasthenia gravis.Time-series analysis: variation of anti-acetylcholine receptor antibody titer in myasthenia gravis is related to incidence of Mycoplasma pneumoniae and influenza virus infections.Health-related quality-of-life and treatment targets in myasthenia gravis.Prognostic factors and health-related quality of life in ocular Myasthenia Gravis (OMG).Myasthenia gravis: sleep quality, quality of life, and disease severity.Characteristics of late-onset myasthenia gravis.Late onset myasthenia gravis and carcinoid tumour: paraneoplastic syndrome?Late-onset myasthenia gravis is predisposed to become generalized in the elderly.Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark.Change in myasthenia gravis epidemiology in Trento, Italy, after twenty years.The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
P2860
Q24595915-F85B4335-D5C5-4955-9534-97FC68E7AA3DQ33611231-C5C857C3-DBDB-4275-BA61-82D1AD9FC3E1Q34057165-68AAA259-D6F1-46F2-980A-F0381D5442D0Q35886852-80858766-E076-484A-AD83-E46B1D3E072AQ36226648-7C54D570-54B3-4C0D-89FB-B3C0A62B86C0Q36326622-BAB9D94A-A344-4930-9630-67D6C6370922Q36783864-4C7FD62B-E866-441F-B05D-8622E4A04EFDQ37124330-96F4703A-BFE7-4799-8128-F1696C1709D8Q37727987-163CB492-BCF2-4E5A-8D41-8A86F7B9D7D3Q38070759-CF048ADE-4A3F-4A84-A1CB-D40E2DE079A3Q38713587-B498098A-C489-48AD-B9FD-A585B6CA5F58Q38969032-3A757B82-CAAB-4DD5-AA2B-AA4D4B9DB63FQ40017924-E34ECED7-3FBC-4DE1-ADDF-5389D63342B3Q42287591-129471F6-0B23-43DE-95EA-0ECD25429938Q43057271-62D5ECE2-B8C4-4F83-9E6A-033388A3C4D7Q43910058-F32A5A3D-5315-4F1D-A038-6C19418FDAF2Q44800354-2399F7C6-D97B-48DB-AE89-D3B88A158E36Q45096052-F25DFEB5-653E-49DE-BDC9-81FB40CBF351Q45324299-88192717-01EB-4164-AAFD-1449A0956110Q48085548-160D2EB0-3A4E-4286-B970-03B09FA383B3Q48135299-E3FE4B4E-91B2-4AD7-B0AD-9B5E3434F7E2Q48232989-A40B1169-AD49-4028-83D8-C25DF3F63978Q48703896-1AC47556-9793-4F42-A521-037D804701D6Q50093416-D7113956-F6E0-4A6A-AAA4-A164EECE0B76Q50318197-C2AE410E-9C77-4C5A-8A79-BB2FA8B17D5CQ50566716-4575E223-E2AA-4756-B886-350BCC7D4A6BQ51167258-B9D9970A-56CA-47C1-8042-AD2A873CA9BEQ54494987-D2CEA530-EED7-46B5-AEBB-354F621AA544
P2860
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@en
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@nl
type
label
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@en
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@nl
prefLabel
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@en
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@nl
P1433
P1476
Increasing incidence of late-onset anti-AChR antibody-seropositive myasthenia gravis.
@en
P2093
Finn E Somnier
P304
P356
10.1212/01.WNL.0000176067.32186.A3
P407
P577
2005-09-01T00:00:00Z